DGS Capital Management, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1900110 JERSEY CITY, NJ

Position in REGN

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$320,645

+$85,225 QoQ

Shares Held

415

+36.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

14 quarters on record

Voting authority Sole 83% Shared 0% None 17%

Healthcare · as of Mar 31, 2026

DGS Capital Management, LLC holds $3,182,420 across 10 Biotechnology names. REGN ranks #4 (10.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	6,682	$628,909
2	EXEL	Exelixis, Inc.	14,116	$605,435
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,310	$584,967
4	REGN	Regeneron Pharmaceuticals, Inc. This page	415	$320,645
5	JAZZ	Jazz Pharmaceuticals plc	1,536	$290,380
6	GMAB	Genmab A/S	10,173	$272,941
7	RPRX	Royalty Pharma plc	5,417	$259,853
8	ZVRA	Zevra Therapeutics, Inc.	14,810	$138,029

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$320,645	415	+36.1%	Shares	Sole	2026-04-28
2025-12-31	$235,420	305	-28.9%	Shares	Sole	2026-02-24
2024-09-30	$450,981	429	+13.8%	Shares	Sole	2024-12-10
2024-06-30	$396,238	377	+0.3%	Shares	Sole	2024-12-10
2024-03-31	$361,896	376	0.0%	Shares	Sole	2024-04-15
2023-12-31	$330,237	376	-0.3%	Shares	Sole	2024-01-30
2023-09-30	$310,255	377	-3.1%	Shares	Sole	2024-01-30
2023-06-30	$279,512	389	-4.0%	Shares	Sole	2024-01-30
2023-03-31	$332,776	405	-4.0%	Shares	Sole	2023-06-16
2022-12-31	$304,468	422	-15.3%	Shares	Sole	2023-02-21
2022-09-30	$343,057	498	+0.8%	Shares	Sole	2023-02-21
2022-06-30	$292,018	494	+16.8%	Shares	Sole	2022-07-28
2022-03-31	$295,431	423	-7.6%	Shares	Sole	2022-05-05
2021-12-31	$289,236	458	—	Shares	Sole	2022-01-28
No filing history on record for this holder in this stock.